FIRM FIXED PRICE

CAREDX, INC. - GENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE)

PIID: 36C24924N0581
Signed Date: Feb 17, 2026Effective Date: Sep 23, 2024End Date: Closed on Sep 22, 2025
Award $
$530K
Vendor
CAREDX, INC.
NAICS
541380
Signed Date
Feb 17, 2026

Key Details

Dollars Obligated
$529,917.92
Base & All Options
$-113,248.79
Awarding Sub-Agency
Department of Veterans Affairs
Product Service Code
Q301 - REFERENCE LABORATORY TESTING
Extent Competed
NOT COMPETED
Place of Performance
MURFREESBORO, TN, 371294356, CD-TN-04

Description

GENETIC BLOOD TESTING FOR TRANSPLANT PATIENTS (ALLOMAP AND ALLOSURE)

Context & Analysis

On Feb 17, 2026, Department of Veterans Affairs obligated $529,917.92 to CAREDX, INC. for genetic blood testing for transplant patients (allomap and allosure). The award is classified under NAICS 541380 — TESTING LABORATORIES AND SERVICES and issued as a firm fixed price contract. Competition extent: not competed. Performance is located in MURFREESBORO, TN.

Contractor Information

Contractor: CAREDX, INC.
UEI: Y371A27ZEUM4
CAGE Code: 53C84
Location: BRISBANE, CA
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related